These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 630791)

  • 41. Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin.
    Pai MP; Norenberg JP; Anderson T; Goade DW; Rodvold KA; Telepak RA; Mercier RC
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2741-7. PubMed ID: 17548489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doxorubicin clearance in the obese.
    Rodvold KA; Rushing DA; Tewksbury DA
    J Clin Oncol; 1988 Aug; 6(8):1321-7. PubMed ID: 3411343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.
    Resar RK; Walson PD; Fritz WL; Perry DF; Barbee RA
    Chest; 1979 Jul; 76(1):11-6. PubMed ID: 36261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of theophylline in infants with bronchiolitis.
    Franko TG; Powell DA; Nahata MC
    Eur J Clin Pharmacol; 1982; 23(2):123-7. PubMed ID: 7140801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of theophylline in infancy.
    Simons FE; Simons KJ
    J Clin Pharmacol; 1978 Oct; 18(10):472-6. PubMed ID: 711929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
    Jaber LA; Ducharme MP; Halapy H
    Ther Drug Monit; 1996 Feb; 18(1):6-13. PubMed ID: 8848822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aminoglycoside dosing weight correction factors for patients of various body sizes.
    Traynor AM; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1995 Feb; 39(2):545-8. PubMed ID: 7726530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of cigarette smoking and sex on theophylline disposition.
    Powell JR; Thiercelin JF; Vozeh S; Sansom L; Riegelman S
    Am Rev Respir Dis; 1977 Jul; 116(1):17-23. PubMed ID: 879596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theophylline kinetics in chronic obstructive airway disease in the elderly.
    Au WY; Dutt AK; DeSoyza N
    Clin Pharmacol Ther; 1985 Apr; 37(4):472-8. PubMed ID: 3919989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative pharmacokinetics of theophylline and aminophylline in man.
    Aslaksen A; Bakke OM; Vigander T
    Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of caffeine on circulating theophylline levels in beagle dogs.
    Tse FL; Valia KH; Szeto DW; Raimondo TJ; Koplowitz B
    J Pharm Sci; 1981 Apr; 70(4):395-9. PubMed ID: 7229951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of size and frequency of oral doses of charcoal on theophylline clearance.
    Park GD; Radomski L; Goldberg MJ; Spector R; Johnson GF; Quee CK
    Clin Pharmacol Ther; 1983 Nov; 34(5):663-6. PubMed ID: 6627827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of cimetidine on theophylline pharmacokinetics at steady state.
    Lalonde RL; Koob RA; McLean WM; Balsys AJ
    Chest; 1983 Feb; 83(2):221-4. PubMed ID: 6822105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients.
    Turner RB; Cumpston A; Sweet M; Briggs F; Slain D; Wen S; Craig M; Hamadani M; Petros W
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1830-3. PubMed ID: 26824940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced biotransformation of theophylline in marihuana and tobacco smokers.
    Jusko WJ; Schentag JJ; Clark JH; Gardner M; Yurchak AM
    Clin Pharmacol Ther; 1978 Oct; 24(4):405-10. PubMed ID: 688731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.